FB BANCORP INC (FBLA) Fundamental Analysis & Valuation

NASDAQ:FBLA • US31425A1097

Current stock price

13.97 USD
-0.08 (-0.57%)
Last:

This FBLA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. FBLA Profitability Analysis

1.1 Basic Checks

  • FBLA had positive earnings in the past year.
  • In the past year FBLA had a positive cash flow from operations.
FBLA Yearly Net Income VS EBIT VS OCF VS FCFFBLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 20M 40M

1.2 Ratios

  • The Return On Assets of FBLA (0.10%) is worse than 91.22% of its industry peers.
  • FBLA's Return On Equity of 0.40% is on the low side compared to the rest of the industry. FBLA is outperformed by 91.22% of its industry peers.
Industry RankSector Rank
ROA 0.1%
ROE 0.4%
ROIC N/A
ROA(3y)-0.1%
ROA(5y)N/A
ROE(3y)-0.26%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FBLA Yearly ROA, ROE, ROICFBLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 1 -1

1.3 Margins

  • With a Profit Margin value of 2.40%, FBLA is not doing good in the industry: 91.49% of the companies in the same industry are doing better.
  • FBLA's Profit Margin has declined in the last couple of years.
  • The Operating Margin and Gross Margin are not available for FBLA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 2.4%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-9.95%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FBLA Yearly Profit, Operating, Gross MarginsFBLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 -5 -10

4

2. FBLA Health Analysis

2.1 Basic Checks

  • FBLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • FBLA has less shares outstanding than it did 1 year ago.
  • There is no outstanding debt for FBLA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FBLA Yearly Shares OutstandingFBLA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 5M 10M 15M
FBLA Yearly Total Debt VS Total AssetsFBLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • There is no outstanding debt for FBLA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC11.68%
FBLA Yearly LT Debt VS Equity VS FCFFBLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
FBLA Yearly Current Assets VS Current LiabilitesFBLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 20M 40M 60M 80M 100M

1

3. FBLA Growth Analysis

3.1 Past

  • FBLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 123.56%, which is quite impressive.
  • Measured over the past years, FBLA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.38% on average per year.
  • Looking at the last year, FBLA shows a very negative growth in Revenue. The Revenue has decreased by -21.55% in the last year.
  • Measured over the past years, FBLA shows a decrease in Revenue. The Revenue has been decreasing by -6.66% on average per year.
EPS 1Y (TTM)123.56%
EPS 3Y-17.38%
EPS 5YN/A
EPS Q2Q%74.07%
Revenue 1Y (TTM)-21.55%
Revenue growth 3Y-6.66%
Revenue growth 5YN/A
Sales Q2Q%-112.04%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FBLA Yearly Revenue VS EstimatesFBLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 20M 40M 60M

0

4. FBLA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 174.63, FBLA can be considered very expensive at the moment.
  • FBLA's Price/Earnings ratio is rather expensive when compared to the industry. FBLA is more expensive than 90.69% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.54. FBLA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 174.63
Fwd PE N/A
FBLA Price Earnings VS Forward Price EarningsFBLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FBLA Per share dataFBLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. FBLA Dividend Analysis

5.1 Amount

  • FBLA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

FBLA Fundamentals: All Metrics, Ratios and Statistics

FB BANCORP INC

NASDAQ:FBLA (4/30/2026, 3:57:58 PM)

13.97

-0.08 (-0.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Industry Strength71.43
Industry Growth91.3
Earnings (Last)03-18
Earnings (Next)05-11
Inst Owners35.96%
Inst Owner Change-0.02%
Ins Owners7.7%
Ins Owner Change101.55%
Market Cap239.73M
Revenue(TTM)52.14M
Net Income(TTM)1.25M
AnalystsN/A
Price TargetN/A
Short Float %3.16%
Short Ratio3.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 174.63
Fwd PE N/A
P/S 4.6
P/FCF N/A
P/OCF 86.92
P/B 0.76
P/tB 0.76
EV/EBITDA N/A
EPS(TTM)0.08
EY0.57%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)0.16
OCFY1.15%
SpS3.04
BVpS18.32
TBVpS18.27
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.74319 (-58.89%)
Profitability
Industry RankSector Rank
ROA 0.1%
ROE 0.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.4%
GM N/A
FCFM N/A
ROA(3y)-0.1%
ROA(5y)N/A
ROE(3y)-0.26%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-9.95%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 215.47%
Cap/Sales 12.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC11.68%
ROIC/WACCN/A
Cap/Depr(3y)185.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)11.43%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)123.56%
EPS 3Y-17.38%
EPS 5YN/A
EPS Q2Q%74.07%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.55%
Revenue growth 3Y-6.66%
Revenue growth 5YN/A
Sales Q2Q%-112.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y169.24%
OCF growth 3Y-61.21%
OCF growth 5YN/A

FB BANCORP INC / FBLA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FB BANCORP INC (FBLA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to FBLA.


What is the valuation status for FBLA stock?

ChartMill assigns a valuation rating of 0 / 10 to FB BANCORP INC (FBLA). This can be considered as Overvalued.


What is the profitability of FBLA stock?

FB BANCORP INC (FBLA) has a profitability rating of 1 / 10.